Probiotic use in clinical practice: what are the risks?
- PMID: 16762934
- DOI: 10.1093/ajcn/83.6.1256
Probiotic use in clinical practice: what are the risks?
Abstract
Probiotics have been advocated for the prevention and treatment of a wide range of diseases, and there is strong evidence for their efficacy in some clinical scenarios. Probiotics are now widely used in many countries by consumers and in clinical practice. Given the increasingly widespread use of probiotics, a thorough understanding of their risks and benefits is imperative. In this article we review the safety of probiotics and discuss areas of uncertainty regarding their use. Although probiotics have an excellent overall safety record, they should be used with caution in certain patient groups-particularly neonates born prematurely or with immune deficiency. Because of the paucity of information regarding the mechanisms through which probiotics act, appropriate administrative regimens, and probiotic interactions, further investigation is needed in these areas. Finally, note that the properties of different probiotic species vary and can be strain-specific. Therefore, the effects of one probiotic strain should not be generalized to others without confirmation in separate studies. Careful consideration should be given to these issues before patients are advised to use probiotic supplements in clinical practice.
Similar articles
-
Lactobacillus sepsis associated with probiotic therapy.Pediatrics. 2005 Jan;115(1):178-81. doi: 10.1542/peds.2004-2137. Pediatrics. 2005. PMID: 15629999
-
Safety of probiotics used to reduce risk and prevent or treat disease.Evid Rep Technol Assess (Full Rep). 2011 Apr;(200):1-645. Evid Rep Technol Assess (Full Rep). 2011. PMID: 23126627 Free PMC article. Review.
-
A meta-analysis of probiotic efficacy for gastrointestinal diseases.PLoS One. 2012;7(4):e34938. doi: 10.1371/journal.pone.0034938. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22529959 Free PMC article.
-
Health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12 in children.Postgrad Med. 2020 Jun;132(5):441-451. doi: 10.1080/00325481.2020.1731214. Epub 2020 Feb 26. Postgrad Med. 2020. PMID: 32059116 Review.
-
The therapeutic effect of probiotic bacteria on gastrointestinal diseases.Adv Clin Exp Med. 2013 Sep-Oct;22(5):759-66. Adv Clin Exp Med. 2013. PMID: 24285463 Review.
Cited by
-
Gastrointestinal cancer resistance to treatment: the role of microbiota.Infect Agent Cancer. 2024 Oct 5;19(1):50. doi: 10.1186/s13027-024-00605-3. Infect Agent Cancer. 2024. PMID: 39369252 Free PMC article. Review.
-
Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium.Sci Rep. 2016 Jun 6;6:27572. doi: 10.1038/srep27572. Sci Rep. 2016. PMID: 27264309 Free PMC article.
-
Deciphering the Potential of Probiotics in Vaccines.Vaccines (Basel). 2024 Jun 26;12(7):711. doi: 10.3390/vaccines12070711. Vaccines (Basel). 2024. PMID: 39066349 Free PMC article. Review.
-
Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications.Clin Exp Immunol. 2007 Dec;150(3):531-8. doi: 10.1111/j.1365-2249.2007.03522.x. Epub 2007 Oct 22. Clin Exp Immunol. 2007. PMID: 17956582 Free PMC article.
-
Probiotics, prebiotics and amelioration of diseases.J Biomed Sci. 2019 Jan 4;26(1):3. doi: 10.1186/s12929-018-0493-6. J Biomed Sci. 2019. PMID: 30609922 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical